Skip to content

Clinical study for the safety and efficacy of Baska mask for minimally invasive surgery in thoracic surgery

Clinical study for the safety and efficacy of Baska laryngeal mask for minimally invasive surgery in thoracic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026454
Enrollment
Unknown
Registered
2019-10-10
Start date
2019-09-30
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumors of the mediastinum

Interventions

TEAS group:Use Baska Mask as ventilation tool
Control group:Use LMA Supreme as ventilation tool

Sponsors

General Hospital of Northern Theater Command of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for general anesthesia with Da Vinci system or thoracoscopic mediastinal mass resection or Da Vinci system or thoracoscopic wedge lobectomy; 2. Aged 18-70years old; 3. BMI 18-30kg/m2, ASA I-III; 4. Fully understand about the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Recent upper respiratory tract infections; 2) Symptomatic hiatal hernia or severe esophageal reflux disease; 3) Patients with a history of laryngospasm and bronchospasm in the past; 4) exclude patients with known or predicted difficult airways; 5) Patients with extensive pleural adhesions or who had undergone thoracic surgery; 6) Patients with hypoxemia or hypercapnia; 7) Pulmonary sequestration should be performed to protect the healthy side of the lung.

Design outcomes

Primary

MeasureTime frame
oropharyngeal leak pressure;

Secondary

MeasureTime frame
number of insertions;Effective insertion time;Glottic View Scoring;Peak airway pressure;Ventilation quality score;Operative visual field exposure;Blood gas analysis;Perioperative monitoring indexes of anaesthesia;Operative time;Time from awakening to removal of laryngeal mask;Laryngeal mask-related complications;ICU Residence Time;Postoperative to discharge days;

Countries

China

Contacts

Public ContactDiao Yugang

General Hospital of Northern Theater Command of the Chinese People's Liberation Army

diao72@163.com+86 15309881160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026